Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1631 1632 1633 1657 1799 3774
This examiner grants 24% of resolved cases
Laura J. Schuberg is an examiner in Art Unit 1631 of Tech Center 3700, with 542 resolved cases. Her allowance rate is 23.6%, which indicates a challenging environment for applicants. This statistical profile suggests that the majority of applications reaching a final resolution under her review do not result in a patent grant.
The interview lift for this examiner is 37.0%, which is a critical metric for practitioners. This lift indicates that the 23.6% baseline allowance rate can be improved through direct communication. Given the difficulty of securing a grant in Art Unit 1631, an interview should be considered an effective strategy for addressing examiner concerns.
The median days to allowance is 1616, reflecting a very long prosecution cycle. This 1616-day pendency, combined with the 23.6% allowance rate, suggests a rigorous and potentially lengthy examination process. Practitioners should be prepared for an extended timeline and should leverage the 37.0% interview lift early to improve their chances of success.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19042945 | IFNy AND TNFa CO-STIMULATION OF MESENCHYMAL STROMAL CELLS DERIVED FROM MINOR SALIVARY (LABIAL) GLANDS FOR THERAPEUTIC USE | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18819158 | Generating Vasculogenic Cell Populations | Non-Final OA | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 17867135 | PATCH GRAFT COMPOSITIONS FOR CELL ENGRAFTMENT | Final Rejection | The University of North Carolina at Chapel Hill |
| 16006460 | PATCH GRAFT COMPOSITIONS FOR CELL ENGRAFTMENT | Non-Final OA | The University of North Carolina at Chapel Hill |
| 18924826 | MESENCHYMAL STEM CELLS FOR ORAL INFLAMMATION TREATMENT | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18484137 | ENGINEERED VASCULAR TISSUE MODELS | Non-Final OA | The Johns Hopkins University |
| 16596495 | COMPOSITIONS AND METHODS FOR OBTAINING STEM CELL DERIVED LUNG TISSUE, AND RELATED USES THEROF | Non-Final OA | The Regents of the University of Michigan |
| 18705362 | METHOD FOR PRODUCING MILK LIKE PRODUCTS | Non-Final OA | SOCIETE DES PRODUITS NESTLE S.A. |
| 18020419 | DISSOLVABLE GELATIN-BASED MICROCARRIERS GENERATED THROUGH DROPLET MICROFLUIDICS FOR EXPANSION AND CULTURE OF MESENCHYMAL STROMAL CELL | Non-Final OA | Massachusetts Institute of Technology |
| 16984531 | METABOLICALLY OPTIMIZED CELL CULTURE | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 15130780 | METABOLICALLY OPTIMIZED CELL CULTURE | Non-Final OA | REGENERON PHARMACEUTICALS, INC. |
| 17047411 | METHODS AND COMPOSITIONS FOR FORMULATING AND DISPENSING PHARMACEUTICAL FORMULATIONS | Final Rejection | Pluri Biotech Ltd. |
| 19264712 | UMBILICAL LINING-DERIVED STEM CELLS FOR TREATING IDIOPATHIC INFLAMMATORY MYOPATHY | Final Rejection | Restem LLC |
| 19050638 | TISSUE DECONTAMINATION AND PRESERVATION SYSTEM | Non-Final OA | The Curators of the University of Missouri |
| 18194781 | METHODS FOR ISOLATING AND CULTURING LIVING CELLS USING METHOD OF PERMEABILIZING CELL MEMBRANE | Final Rejection | SEOUL NATIONAL UNIVERSITY HOSPITAL |
| 18145922 | PRODUCTION METHOD FOR SYNOVIUM-DERIVED MESENCHYMAL STEM CELLS AND PRODUCTION METHOD FOR CELL PREPARATION FOR JOINT MEDICAL TREATMENT | Non-Final OA | National University Corporation Tokyo Medical and Dental University |
| 18482096 | STIFFNESS TUNABLE BIOMIMETIC DECELLULARIZED EXTRACELLULAR MATRIX-BASED MATERIAL SYSTEMS | Non-Final OA | The Trustees of the University of Pennsylvania |
| 18650265 | FASCICULATED NERVE GRAFTS, METHODS OF MAKING THE SAME, AND METHODS OF TREATMENT USING THE SAME | Non-Final OA | Axogen Corporation |
| 17775172 | Extracellular Matrix Gels, and Organoid Cultures Comprising the Same | Final Rejection | UCL BUSINESS LTD. |
| 18835286 | METHOD FOR PRODUCING LUNG MESENCHYMAL CELLS AND LUNG MESENCHYMAL CELLS | Non-Final OA | KYOTO UNIVERSITY |
| 18784235 | Organoid Compositions | Non-Final OA | OSAKA UNIVERSITY |
| 16078002 | HUMAN FUNCTIONAL CORNEAL ENDOTHELIAL CELL AND APPLICATION THEREOF | Non-Final OA | KYOTO PREFECTURAL PUBLIC UNIVERSITY CORPORATION |
| 18146541 | METHOD FOR WASHING AND FINISHING A GROWN CELL MASS | Non-Final OA | The Upside Group Inc. |
| 17754106 | CANNABIDIOL ADJUVANT THERAPY FOR TREATMENT OF DISC DEGENERATIVE DISEASE | Final Rejection | FIGENE, LLC |
| 18287435 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PARKINSON'S DISEASE, AND PREPARATION METHOD THEREOF | Final Rejection | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
| 18324601 | TISSUE GELL FOR TRANSPLANTATION USING DECELLULARIZED EXTRACELLULAR MATRIX AND METHOD OF PREPARING THE SAME | Non-Final OA | CELLARTGEN INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy